- Investing.com
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion set, dispensing and injection syringes, detained needles, nebulizer, and vacuum blood collection tubes; over-the-counter products; and APIs for treatment of cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injection. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Metrics to compare | 002422 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002422PeersSector | |
---|---|---|---|---|
P/E Ratio | 23.4x | 28.5x | −0.5x | |
PEG Ratio | −2.55 | −0.41 | 0.00 | |
Price/Book | 2.5x | 2.4x | 2.6x | |
Price / LTM Sales | 2.9x | 3.1x | 3.3x | |
Upside (Analyst Target) | 18.2% | 10.1% | 43.3% | |
Fair Value Upside | Unlock | −6.7% | 6.9% | Unlock |